Literature DB >> 19141715

Human papilloma virus type 69 identified in a clinically aggressive plantar verruca from an HIV-positive patient.

Jeffrey M Whitaker1, Joel M Palefsky, Maria Da Costa, Christy M King, James S Johnston, Peter Barbosa.   

Abstract

BACKGROUND: Verrucae are caused by infection of epidermal keratinocytes by human papilloma virus (HPV). Although there are currently more than 100 known types of HPV, certain lesions are consistently caused by infection with one or a few types. Recent studies have identified the presence of unusual HPV types in anogenital and cervical condylomata (warts) of patients infected with human immunodeficiency virus (HIV). Although cutaneous verrucae are typically caused by HPV-1, HPV-2, and HPV-4, infection with HIV may predispose an individual to infection with an unusual HPV type.
METHODS: We report the detection of a rare HPV type in a clinically aggressive plantar verruca from an HIV-positive patient. The viral DNA from this specimen was analyzed to identify the predominant HPV type. To complete this analysis, HPV DNA was extracted from the formalin-fixed specimen, followed by polymerase chain reaction with consensus HPV primers and digestion with a specific group of restriction endonucleases. The fragments were separated on an agarose gel, and the restriction fragment length polymorphism pattern was compared with known patterns for identification of the specific HPV type.
RESULTS: Identification of HPV-69, an HPV type previously reported to be rare and associated with dysplastic lesions, was confirmed by HPV DNA dot-blot hybridization with specific DNA probes for each known HPV type.
CONCLUSIONS: Plantar verrucae in HIV-positive patients may be associated with unusual HPV types and should be analyzed and treated aggressively given the potential for a more distinct clinical manifestation. Additional lesional analysis studies are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141715     DOI: 10.7547/0980008

Source DB:  PubMed          Journal:  J Am Podiatr Med Assoc        ISSN: 1930-8264


  2 in total

1.  High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.

Authors:  Heather M Walline; Thomas E Carey; Christine M Goudsmit; Emily L Bellile; Gypsyamber D'Souza; Lisa A Peterson; Jonathan B McHugh; Sara I Pai; J Jack Lee; Dong M Shin; Robert L Ferris
Journal:  Mol Cancer Res       Date:  2016-11-29       Impact factor: 5.852

2.  HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.

Authors:  Alyssa M Cornall; Marin Poljak; Suzanne M Garland; Samuel Phillips; Dorothy A Machalek; Jeffrey H Tan; Michael A Quinn; Sepehr N Tabrizi
Journal:  Papillomavirus Res       Date:  2017-10-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.